跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Butylidenephthalide
首页
药物
Butylidenephthalide
Investigational
Small Molecule
Butylidenephthalide
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
CAS 编号
551-08-6
UNII ID
S9178G4B3F
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Angelicae sinensis extracts useful for treatment of cancers
US 2006110469 A1
申请人: BUDDHIST TZU CHI GENERAL HOSPI
优先权: 2005
US
4 件公开
USE OF N-BUTYLIDENEPHTHALIDE IN DOPAMINERGIC PROGENITOR CELL TRANSPLANTATION
US 2020063098 A1
申请人: ULTRA MICRORIGIN BIOMEDICAL TECH CO LTD
优先权: 2018
CN
US
3 件公开
ANTICANCER FORMULATION
US 2011165201 A1
申请人: NAT UNIV DONG HWA
优先权: 2011
US
3 件公开
Method for treating pancreatic cancer
US 9872912 B2
申请人: UNIV CHINA MEDICAL
优先权: 2014
CN
US
2 件公开
Applications of butylidenephthalide
US 11920157 B2
申请人: UNIV NATIONAL DONG HWA
优先权: 2016
CN
US
2 件公开
Use of Z-butylidenephthalide in activating autoimmune system
US 10688128 B2
申请人: EVERFRONT BIOTECH INC
优先权: 2016
CN
US
2 件公开
Method for treating brain cancer or reducing temozolomide-resistance of brain cancer cells
US 9018251 B2
申请人: HARN HORNG-JYH
优先权: 2011
US
2 件公开
Uses of N-butylidenephthalide in treating a liver injury and improving liver function
US 8927601 B2
申请人: CHIOU TZYY-WEN
优先权: 2011
US
2 件公开
A set of blood vessel dilating effective ingredients from Ligusticum chuanxiong volatile oil
CN 102475702 A
申请人: INST CHINESE MATERIA MEDICA CHINA ACADEMY OF CMS
优先权: 2010
CN
Preparation containing ligustilide type component for treating cardio-cerebrovascular disease and preparation method thereof
CN 102631387 A
申请人: UNIV TIANJIN
优先权: 2012
CN
第 1 / 3 页
上一页
下一页
药物
反馈